Matching slides 60,557
Current window 41,431-41,460
Pages 2,019
Rows per page 30
Component: Tableclear collectionreset all

Component

41,431-41,460 of 60,557

filter-aware
36
The table provides a detailed breakdown of various non-GAAP adjustments including amortization, impairments, and restructuring costs.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
37
Includes a secondary table for noncontrolling interest adjustments.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
38
The table includes adjustments for foreign exchange rates, acquisitions, and divestitures to arrive at organic revenue figures.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
39
The table includes adjustments for exchange rates, acquisitions, and divestitures to arrive at organic revenue figures.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
40
The table provides a bridge between reported operating cash flow and adjusted cash flow by adding back various non-recurring or specific costs.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
41
The table breaks down adjustments for legal settlements, transformation costs, separation/IPO costs, interest payments, and exchange fees.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
42
The table provides a detailed breakdown of adjustments including impairments, restructuring costs, and other non-GAAP adjustments.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
43
Includes detailed line-item adjustments for impairments, restructuring, and other non-GAAP items.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
05
The slide uses a comparison matrix to contrast 'Others' with 'Advantage' (Benson Hill) across five pillars, emphasizing a 6-10 year lead.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
The slide uses a timeline-based progression (2023 -> Proof of Value -> Platform Innovation) mapped against product generations.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
Includes reconciliation for mark-to-market timing differences and highlights key operational drivers.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · FinancialsLoop · Why Now1 hit
20
Includes adjustments for 'Open Mark-to-Market Timing differences' and excludes 'Fresh Business'.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · Financials1 hit
21
The slide presents a financial bridge/reconciliation of guidance metrics.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · Financials1 hit
26
USD in thousands, except per share information.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations 1 hit
27
Financial statement presentation; values in thousands USD.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations 1 hit
28
Standard GAAP cash flow statement format.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations 1 hit
29
Includes two distinct reconciliation tables: one for Adjusted EBITDA and one for Free Cash Flow.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations 1 hit
12
Bigbear AI | Investor Presentation Deck | 29 slidesBigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · Competition1 hit
14
Bigbear AI | Investor Presentation Deck | 29 slidesBigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · Team1 hit
18
The slide uses a pie chart comparison to illustrate a strategic shift in revenue mix.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · Financials1 hit
20
Includes footnotes regarding GAAP reconciliation and pro forma comparisons.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations Beat · Financials1 hit
26
Standard financial reconciliation table showing adjustments for non-cash and non-recurring items.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations 1 hit
27
The table shows adjustments for non-recurring items like restructuring charges, transaction expenses, and goodwill impairment.Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations 1 hit
08
The slide uses a horizontal bar chart integrated into a table to represent clinical trial phases.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Solution1 hit
21
Includes specific clinical trial safety metrics and footnotes regarding data definitions.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
22
The table displays specific drug administration schedules (mg/kg) for different cycle lengths and days.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
23
Includes abbreviations for indications (LMS, UPS, NSCLC) and trial design details.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
30
The slide uses a table to present clinical trial outcomes (PR/CR) and safety data.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
32
The table compares dosing schedules for a clinical trial drug.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
33
BA3021 Ozuriftamab VedotinBioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit